ATE102043T1 - Empfaenglichmachen von saeugetieren fuer beschleunigte gewebereparatur. - Google Patents

Empfaenglichmachen von saeugetieren fuer beschleunigte gewebereparatur.

Info

Publication number: ATE102043T1
Authority: AT; Austria
Prior art keywords: mammals; presenting; tissue repair; accelerated tissue; accelerated
Prior art date: 1990-04-04

Application number

AT91908101T

Other languages

English (en)

Inventor

Edward P Amento

L Steven Beck

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-04-04

Filing date

1991-03-20

Publication date

1994-03-15

1991-03-20 Application filed by Genentech Inc filed Critical Genentech Inc

1994-03-15 Application granted granted Critical

1994-03-15 Publication of ATE102043T1 publication Critical patent/ATE102043T1/de

Links

241000124008 Mammalia Species 0.000 title abstract 3
230000017423 tissue regeneration Effects 0.000 title abstract 2
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 abstract 2
230000000451 tissue damage Effects 0.000 abstract 2
231100000827 tissue damage Toxicity 0.000 abstract 2

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Laser Surgery Devices (AREA)
Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

AT91908101T 1990-04-04 1991-03-20 Empfaenglichmachen von saeugetieren fuer beschleunigte gewebereparatur. ATE102043T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/504,495 US5108989A (en)	1990-04-04	1990-04-04	Method of predisposing mammals to accelerated tissue repair
PCT/US1991/001861 WO1991015222A2 (en)	1990-04-04	1991-03-20	Method of predisposing mammals to accelerated tissue repair

Publications (1)

Publication Number	Publication Date
ATE102043T1 true ATE102043T1 (de)	1994-03-15

Family

ID=24006516

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91908101T ATE102043T1 (de)	1990-04-04	1991-03-20	Empfaenglichmachen von saeugetieren fuer beschleunigte gewebereparatur.

Country Status (9)

Country	Link
US (1)	US5108989A (de)
EP (1)	EP0527787B1 (de)
JP (1)	JPH05506030A (de)
AT (1)	ATE102043T1 (de)
CA (1)	CA2078547A1 (de)
DE (1)	DE69101316T2 (de)
DK (1)	DK0527787T3 (de)
ES (1)	ES2052378T3 (de)
WO (1)	WO1991015222A2 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5824297A (en) *	1990-06-25	1998-10-20	Oncogene Science, Inc.	Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
US6077823A (en) *	1991-03-11	2000-06-20	Creative Biomolecules, Inc.	Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6723698B2 (en) *	1991-03-11	2004-04-20	Curis, Inc.	Methods and compositions for the treatment of motor neuron injury and neuropathy
US6211146B1 (en) *	1991-03-11	2001-04-03	Curis, Inc.	60A protein-induced morphogenesis
CA2363965C (en)	1991-03-11	2010-05-18	Curis, Inc.	Protein-induced morphogenesis
US6495513B1 (en)	1991-03-11	2002-12-17	Curis, Inc.	Morphogen-enhanced survival and repair of neural cells
US5849686A (en) *	1991-03-11	1998-12-15	Creative Biomolecules, Inc.	Morphogen-induced liver regeneration
US6506729B1 (en)	1991-03-11	2003-01-14	Curis, Inc.	Methods and compositions for the treatment and prevention of Parkinson's disease
US6399569B1 (en)	1991-03-11	2002-06-04	Curis, Inc.	Morphogen treatments for limiting proliferation of epithelial cells
US6022853A (en) *	1991-08-30	2000-02-08	Creative Biomolecules, Inc.	Morphogen-enriched dietary composition
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en)	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6204240B1 (en)	1991-11-22	2001-03-20	Genentech, Inc.	TGF-β1 to improve neural outcome
US5681812A (en) *	1991-12-10	1997-10-28	Rush Presbyterian-St. Luke's Medical Center	Methods and compositions for reducing multidrug resistance
CA2125279A1 (en) *	1991-12-10	1993-06-24	John Sayler Coon	Methods and compositions for reducing multi-drug resistance
US5767079A (en) *	1992-07-08	1998-06-16	Celtrix Pharmaceuticals, Inc.	Method of treating ophthalmic disorders using TGF -β
US5817625A (en) *	1992-09-21	1998-10-06	Oncogene Science, Inc.	Methods of prevention of oral mucositis with transforming growth factor beta
US6251920B1 (en)	1993-05-13	2001-06-26	Neorx Corporation	Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) *	1993-05-13	2002-05-28	Neorx Corporation	Method to determine TGF-β
US5847007A (en) *	1993-05-13	1998-12-08	Neorx Corporation	Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US6491938B2 (en)	1993-05-13	2002-12-10	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
CA2149657A1 (en) *	1993-09-29	1995-04-06	Billie M. York	Compositions containing growth factors and antiplastic agents
WO1995009003A1 (en) *	1993-09-29	1995-04-06	Alcon Laboratories, Inc.	Compositions containing growth factors and antimetabolites
US5449671A (en) *	1993-09-29	1995-09-12	Alcon Laboratories, Inc.	Use of TGF-β3, to prevent or retard fistula closure following glaucoma filtration surgery
US5411940A (en) *	1993-09-29	1995-05-02	Alcon Laboratories, Inc.	Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
NZ284214A (en) *	1994-03-31	1997-07-27	Biomed Comm Inc	Extreme dilutions of growth factors, homeopathic compositions, radiotherapy.
US6040431A (en) *	1995-06-07	2000-03-21	Stryker Corporation	Single chain analogs of the TGF-β superfamily (morphons)
CA2223595C (en) *	1995-06-07	2008-08-05	Neorx Corporation	Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
EP0894004B2 (de)	1996-03-22	2007-02-21	Curis, Inc.	Verfahren zur verbesserten funktionelle erholung der motorische koordiination, der sprache oder der sinneswahrnehmung nach trauma oder isch?mie des zns
AU5593398A (en) *	1996-12-05	1998-06-29	Alcon Laboratories, Inc.	The use of inhibitors of tgf-beta's functions to ameliorate ocular pathology
US6117911A (en) *	1997-04-11	2000-09-12	Neorx Corporation	Compounds and therapies for the prevention of vascular and non-vascular pathologies
US20020095157A1 (en) *	1999-07-23	2002-07-18	Bowman Steven M.	Graft fixation device combination
US6179840B1 (en)	1999-07-23	2001-01-30	Ethicon, Inc.	Graft fixation device and method
CA2365376C (en) *	2000-12-21	2006-03-28	Ethicon, Inc.	Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6852330B2 (en)	2000-12-21	2005-02-08	Depuy Mitek, Inc.	Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US6599323B2 (en)	2000-12-21	2003-07-29	Ethicon, Inc.	Reinforced tissue implants and methods of manufacture and use
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
EP1256316A1 (de)	2001-05-07	2002-11-13	Move2Health B.V.	Tragbare Vorrichtung mit einem Beschleunigungssensor und ein Verfahren zur Erzeugung von Befehlen oder Ratschläge
US20040078090A1 (en) *	2002-10-18	2004-04-22	Francois Binette	Biocompatible scaffolds with tissue fragments
US7824701B2 (en) *	2002-10-18	2010-11-02	Ethicon, Inc.	Biocompatible scaffold for ligament or tendon repair
US8197837B2 (en)	2003-03-07	2012-06-12	Depuy Mitek, Inc.	Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US8226715B2 (en) *	2003-06-30	2012-07-24	Depuy Mitek, Inc.	Scaffold for connective tissue repair
US10583220B2 (en) *	2003-08-11	2020-03-10	DePuy Synthes Products, Inc.	Method and apparatus for resurfacing an articular surface
US7316822B2 (en)	2003-11-26	2008-01-08	Ethicon, Inc.	Conformable tissue repair implant capable of injection delivery
US7901461B2 (en) *	2003-12-05	2011-03-08	Ethicon, Inc.	Viable tissue repair implants and methods of use
US11395865B2 (en) *	2004-02-09	2022-07-26	DePuy Synthes Products, Inc.	Scaffolds with viable tissue
US8657881B2 (en) *	2004-04-20	2014-02-25	Depuy Mitek, Llc	Meniscal repair scaffold
US8221780B2 (en) *	2004-04-20	2012-07-17	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US8137686B2 (en)	2004-04-20	2012-03-20	Depuy Mitek, Inc.	Nonwoven tissue scaffold
US7373820B1 (en)	2004-11-23	2008-05-20	James Terry L	Accelerometer for data collection and communication
US8376984B2 (en) *	2005-07-14	2013-02-19	Terry L. James	Apparatus, system, and method to deliver optimal elements in order to enhance the aesthetic appearance of the skin
US20080306762A1 (en) *	2007-06-08	2008-12-11	James Terry L	System and Method for Managing Absenteeism in an Employee Environment
US20090048493A1 (en) *	2007-08-17	2009-02-19	James Terry L	Health and Entertainment Device for Collecting, Converting, Displaying and Communicating Data
MX2010003019A (es) *	2007-09-19	2010-04-30	Pluristem Ltd	Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
US7676332B2 (en) *	2007-12-27	2010-03-09	Kersh Risk Management, Inc.	System and method for processing raw activity energy expenditure data
US20090204422A1 (en) *	2008-02-12	2009-08-13	James Terry L	System and Method for Remotely Updating a Health Station
US20100016742A1 (en) *	2008-07-19	2010-01-21	James Terry L	System and Method for Monitoring, Measuring, and Addressing Stress

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE61346B1 (en) *	1988-11-02	1994-11-02	Genentech Inc	A permeable material to fit around the teeth or gums of a mammal
AU5958090A (en) *	1989-06-29	1991-01-17	United States of America, as represented by the Secretary, U.S. Department of Commerce, The	Method for protecting bone marrow against chemotherapeutic drugs and radiation therapy using transforming growth factor beta 1

1990
- 1990-04-04 US US07/504,495 patent/US5108989A/en not_active Expired - Lifetime
1991
- 1991-03-20 DK DK91908101.8T patent/DK0527787T3/da active
- 1991-03-20 CA CA002078547A patent/CA2078547A1/en not_active Abandoned
- 1991-03-20 EP EP91908101A patent/EP0527787B1/de not_active Expired - Lifetime
- 1991-03-20 JP JP91507583A patent/JPH05506030A/ja active Pending
- 1991-03-20 DE DE69101316T patent/DE69101316T2/de not_active Expired - Lifetime
- 1991-03-20 AT AT91908101T patent/ATE102043T1/de not_active IP Right Cessation
- 1991-03-20 WO PCT/US1991/001861 patent/WO1991015222A2/en not_active Ceased
- 1991-03-20 ES ES91908101T patent/ES2052378T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1991015222A2 (en)	1991-10-17
WO1991015222A3 (en)	1991-11-14
DK0527787T3 (da)	1994-08-22
EP0527787A1 (de)	1993-02-24
EP0527787B1 (de)	1994-03-02
US5108989A (en)	1992-04-28
CA2078547A1 (en)	1991-10-05
JPH05506030A (ja)	1993-09-02
DE69101316T2 (de)	1994-08-11
ES2052378T3 (es)	1994-07-01
DE69101316D1 (de)	1994-04-07

Legal Events

Date	Code	Title	Description
1994-12-15	UEP	Publication of translation of european patent specification
2011-06-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE102043T1 (de)	1994-03-15	Empfaenglichmachen von saeugetieren fuer beschleunigte gewebereparatur.
ES2108278T3 (es)	1997-12-16	Composicion de vacuna con coadyuvantes.
ES2149776T3 (es)	2000-11-16	Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
ES2138691T3 (es)	2000-01-16	Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
PE30891A1 (es)	1991-11-27	Composiciones y metodos terapeuticos sinergicos
ATE373640T1 (de)	2007-10-15	Optische auflösung von methylphenidat mittels 0, 0'-bisaroyl-weinsäuren
ES2090217T3 (es)	1996-10-16	Laca fotosensible.
NO972254D0 (no)	1997-05-16	Monomerer og sammensetninger som kan tverrbindes samt tverrbundede polymerer
ES2071815T3 (es)	1995-07-01	Analogos de delecion de los peptidos conocidos como magaininas.
DE69430538D1 (de)	2002-06-06	2-azylalkyl-oder arylalenyl-cyclopentanheptan-und heptensäuren, derivate und therapeutische anwendung
ES2095068T3 (es)	1997-02-01	Peroxicarbonatos polimericos y procedimiento para prepararlos.
ATE81004T1 (de)	1992-10-15	Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DE69415307D1 (de)	1999-01-28	4-arylisoindol-analgetika
ES2070370T3 (es)	1995-06-01	3,3'-ditiobis(acidos propionicos) y sus esteres.
MX165167B (es)	1992-10-29	Composicion adhesiva instantanea
SE8303700L (sv)	1983-12-29	Terapeutisk komposition
ES2126155T3 (es)	1999-03-16	Nuevos compuestos aminoesteroidales que contienen uretano.
SE8103778L (sv)	1981-12-25	Oxytocinanaloger och sett for framstellning derav
ES2138100T3 (es)	2000-01-01	Procedimiento para la preparacion de 1,5-benzotiazepinas por ciclizacion de esteres aminicos.
ES2166834T3 (es)	2002-05-01	Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus.
KR920003972A (ko)	1992-03-27	프로스타시클린 화합물을 이용한 백내장 치료
ATE62413T1 (de)	1991-04-15	Heilmittel gegen leishmaniose.
ES2176258T3 (es)	2002-12-01	Uso de penciclovir en el tratamiento de la neuralgia post-herpeticas. a
IT1226796B (it)	1991-02-19	Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.
ATE73812T1 (de)	1992-04-15	Thionophosphonsaeureester.